ConductScience.org, home

Paper · 33256240

The Role of BRAF in Metastatic Colorectal Carcinoma-Past, Present, and Future.

Djanani A and 4 others. Int J Mol Sci, 2020. Cited by 17 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. The Role of BRAF in Metastatic Colorectal Carcinoma-Past, Present, and Future. Papers, record 33256240. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33256240

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The Role of BRAF in Metastatic Colorectal Carcinoma-Past, Present, and Future.
PubMed
Journal
Int J Mol Sci
PubMed
Year
2020
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
17
iCite
Relative citation ratio, by iCite
0.57
iCite
Revised in PubMed
2023-11-04
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Djanani AAngela
2Eller SSilvia
3Öfner DDietmarhttps://orcid.org/0000-0001-8909-8566
4Troppmair JJakobhttps://orcid.org/0000-0002-0611-3837
5Maglione MManuelhttps://orcid.org/0000-0003-1479-6129

Source PubMed

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Colorectal NeoplasmsMajor topic
Proto-Oncogene Proteins B-rafMajor topic
Animals
Drug Resistance, Neoplasm
Humans
Molecular Targeted Therapy
Neoplasm Metastasis
Signal Transduction

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References115

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127,198,569PD-L1 expression in colorectal cancer is associated with microsatellite instability, BRAF mutation, medullary morphology and cytotoxic tumor-infiltrating lymphocytes.Mod Pathol2016https://conductscience.org/library/papers/27198569PubMed
218,316,791Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer.J Clin Oncol2008https://conductscience.org/library/papers/18316791PubMed
332,919,890Long-term Clinical Outcome of Trastuzumab and Lapatinib for HER2-positive Metastatic Colorectal Cancer.Clin Colorectal Cancer2020https://conductscience.org/library/papers/32919890PubMed
426,742,998Cancer statistics, 2016.CA Cancer J Clin2016https://conductscience.org/library/papers/26742998PubMed
525,139,339Mismatch repair status and BRAF mutation status in metastatic colorectal cancer patients: a pooled analysis of the CAIRO, CAIRO2, COIN, and FOCUS studies.Clin Cancer Res2014https://conductscience.org/library/papers/25139339PubMed
621,646,616Impact of KRAS and BRAF Gene Mutation Status on Outcomes From the Phase III AGITG MAX Trial of Capecitabine Alone or in Combination With Bevacizumab and Mitomycin in Advanced Colorectal Cancer.J Clin Oncol2011https://conductscience.org/library/papers/21646616PubMed
78,861,899Lessons from hereditary colorectal cancer.Cell1996https://conductscience.org/library/papers/8861899PubMed
819,603,024Prognostic and predictive value of common mutations for treatment response and survival in patients with metastatic colorectal cancer.Br J Cancer2009https://conductscience.org/library/papers/19603024PubMed
932,249,628The discovery and development of binimetinib for the treatment of melanoma.Expert Opin Drug Discov2020https://conductscience.org/library/papers/32249628PubMed
1016,649,144Back to the roots: the remarkable RAF oncogene story.Cell Mol Life Sci2006https://conductscience.org/library/papers/16649144PubMed

Cited by13

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.

PMIDTitleJournalYearIn PapersSource
42,588,662Factors Associated with the Timing of Liver Metastasis After Colorectal Cancer Surgery: A Retrospective Multicenter Study.Cancers (Basel)2026https://conductscience.org/library/papers/42588662PubMed
42,185,244Cost-effectiveness analysis of encorafenib in untreated BRAF V600E-mutant metastatic colorectal cancer in China.Pharmacogenomics J2026https://conductscience.org/library/papers/42185244PubMed
41,439,081Molecular Profiling of KRAS, NRAS, and BRAF in Colorectal Cancer: Insights From a Libyan Cohort.Cureus2025https://conductscience.org/library/papers/41439081PubMed
40,619,745Adagrasib in the treatment of colorectal cancer.Future Oncol2025https://conductscience.org/library/papers/40619745PubMed
40,234,937LINC02167 stabilizes KSR1 mRNA in an m5C-dependent manner to regulate the ERK/MAPK signaling pathway and promotes colorectal cancer metastasis.J Exp Clin Cancer Res2025https://conductscience.org/library/papers/40234937PubMed
40,083,375Precision medicine in colorectal cancer: genomics profiling and targeted treatment.Front Pharmacol2025https://conductscience.org/library/papers/40083375PubMed
39,591,358Expression of Mutated BRAFV595E Kinase in Canine Carcinomas-An Immunohistochemical Study.Vet Sci2024https://conductscience.org/library/papers/39591358PubMed
38,940,668Progress in clinical diagnosis and treatment of colorectal cancer with rare genetic variants.Cancer Biol Med2024https://conductscience.org/library/papers/38940668PubMed
38,136,364In Vitro Organoid-Based Assays Reveal SMAD4 Tumor-Suppressive Mechanisms for Serrated Colorectal Cancer Invasion.Cancers (Basel)2023https://conductscience.org/library/papers/38136364PubMed
36,811,382A Phase Ib/II Study of WNT974 + Encorafenib + Cetuximab in Patients With BRAF V600E-Mutant KRAS Wild-Type Metastatic Colorectal Cancer.Oncologist2023https://conductscience.org/library/papers/36811382PubMed

1 to 10 of 13

See all 13 cited by

Genes26

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33256240

GET https://conductscience.org/api/papers/v1/33256240/references?page=2